SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-18-029595
Filing Date
2018-05-17
Accepted
2018-05-17 17:21:42
Documents
5
Period of Report
2018-07-10

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A tv493196-pre14a.htm PRE 14A 689423
2 GRAPHIC lg_eyegate-pharma.jpg GRAPHIC 10225
3 GRAPHIC sg_stephenfrom.jpg GRAPHIC 5177
4 GRAPHIC tv493196_pc1.jpg GRAPHIC 422985
5 GRAPHIC tv493196_pc2.jpg GRAPHIC 215295
  Complete submission text file 0001144204-18-029595.txt   1589652
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36672 | Film No.: 18844111
SIC: 2834 Pharmaceutical Preparations